Literature DB >> 8430956

Hypersensitivity pneumonitis-like reaction among workers exposed to diphenylmethane [correction to piphenylmethane] diisocyanate (MDI).

O Vandenplas1, J L Malo, M Dugas, A Cartier, A Desjardins, J Lévesque, M A Shaughnessy, L C Grammer.   

Abstract

Isocyanates are well documented as a cause of occupational asthma. A hypersensitivity pneumonitis type of reaction has also been reported but only in a few isolated cases. We investigated nine subjects who complained of respiratory and general symptoms related to workplace exposure. All the subjects had worked in a plant where a resin based on diphenylmethane diisocyanate (MDI) is used in the manufacture of woodchip boards. They underwent inhalation challenges using the MDI resin for progressively increasing periods of time on separate days. In eight subjects, exposure to subirritant amounts of MDI induced a pattern of reaction consistent with hypersensitivity pneumonitis, i.e., significant falls in both FEV1 and FVC associated with a rise in body temperature (> 38 degrees C) and an increase in blood neutrophils (> +2,500/mm3). Bronchoalveolar lavage, performed in two subjects 24 h after the end of challenge exposure, revealed an increase in lymphocytes and neutrophils. Specific immunoglobulin G (IgG) and IgE antibodies to MDI human serum albumin (HSA) conjugates were present in all subjects. We conclude that the MDI resin caused an hypersensitivity pneumonitis type of reaction in at least eight (4.7%) of the 167 potentially exposed workers employed in the plant. These findings indicate that in some workplaces, a hypersensitivity pneumonitis type of reaction may be a more frequent consequence of isocyanate exposure than is usually thought.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8430956     DOI: 10.1164/ajrccm/147.2.338

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  7 in total

1.  Biological monitoring of workers exposed to 4,4'-methylenediphenyl diisocyanate (MDI) in 19 French polyurethane industries.

Authors:  A Robert; P Ducos; J M Francin; P Marsan
Journal:  Int Arch Occup Environ Health       Date:  2006-10-24       Impact factor: 3.015

2.  Biological monitoring of exposure to 1,5-naphthalene diisocyanate and 4,4'-methylenediphenyl diisocyanate.

Authors:  C J Sennbro; C H Lindh; C Mattsson; B A G Jönsson; H Tinnerberg
Journal:  Int Arch Occup Environ Health       Date:  2006-02-28       Impact factor: 3.015

3.  Is specific IgE antibody analysis feasible for the diagnosis of methylenediphenyl diisocyanate-induced occupational asthma?

Authors:  Lygia Therese Budnik; Alexandra M Preisser; Hjalmar Permentier; Xaver Baur
Journal:  Int Arch Occup Environ Health       Date:  2012-04-28       Impact factor: 3.015

4.  Bronchial asthma and COPD due to irritants in the workplace - an evidence-based approach.

Authors:  Xaver Baur; Prudence Bakehe; Henning Vellguth
Journal:  J Occup Med Toxicol       Date:  2012-09-26       Impact factor: 2.646

5.  Prevention guidance for isocyanate-induced asthma using occupational surveillance data.

Authors:  Carolyn Reeb-Whitaker; Naomi J Anderson; David K Bonauto
Journal:  J Occup Environ Hyg       Date:  2013       Impact factor: 2.155

6.  Three simultaneous cases of hypersensitivity pneumonitis and acute lung injury caused by dichloromethane.

Authors:  Kei Takamura; Takahiro Ogi; Makoto Yamamoto; Keisuke Kikuchi
Journal:  Respirol Case Rep       Date:  2016-10-19

7.  Opportunities and obstacles in translating evidence to policy in occupational asthma.

Authors:  Susan M Tarlo; Ahmed A Arif; George L Delclos; Paul Henneberger; Jenil Patel
Journal:  Ann Epidemiol       Date:  2017-03-31       Impact factor: 3.797

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.